182 related articles for article (PubMed ID: 24094723)
1. Medication and suicide risk in schizophrenia: a nested case-control study.
Reutfors J; Bahmanyar S; Jönsson EG; Brandt L; Bodén R; Ekbom A; Osby U
Schizophr Res; 2013 Nov; 150(2-3):416-20. PubMed ID: 24094723
[TBL] [Abstract][Full Text] [Related]
2. Suicide risk and antipsychotic side effects in schizophrenia: nested case-control study.
Reutfors J; Clapham E; Bahmanyar S; Brandt L; Jönsson EG; Ekbom A; Bodén R; Ösby U
Hum Psychopharmacol; 2016 Jul; 31(4):341-5. PubMed ID: 27108775
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipidemia following treatment with antipsychotic medications.
Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study.
Reutfors J; Brandt L; Jönsson EG; Ekbom A; Sparén P; Osby U
Schizophr Res; 2009 Mar; 108(1-3):231-7. PubMed ID: 19176276
[TBL] [Abstract][Full Text] [Related]
5. Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period.
Barak Y; Mirecki I; Knobler HY; Natan Z; Aizenberg D
Psychopharmacology (Berl); 2004 Sep; 175(2):215-9. PubMed ID: 14760515
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic profile and suicide risk in schizophrenia spectrum disorder.
Reutfors J; Bahmanyar S; Jönsson EG; Ekbom A; Nordström P; Brandt L; Ösby U
Schizophr Res; 2010 Nov; 123(2-3):251-6. PubMed ID: 20692815
[TBL] [Abstract][Full Text] [Related]
7. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
8. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.
Gaertner I; Gilot C; Heidrich P; Gaertner HJ
Pharmacopsychiatry; 2002 Mar; 35(2):37-43. PubMed ID: 11951144
[TBL] [Abstract][Full Text] [Related]
9. Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study.
Ringbäck Weitoft G; Berglund M; Lindström EA; Nilsson M; Salmi P; Rosén M
Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):290-8. PubMed ID: 24435842
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
[TBL] [Abstract][Full Text] [Related]
11. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Citrome L; Jaffe A; Levine J
Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
[TBL] [Abstract][Full Text] [Related]
12. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.
Hsieh PH; Hsiao FY; Gau SS; Gau CS
J Clin Psychopharmacol; 2013 Jun; 33(3):299-305. PubMed ID: 23609396
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up.
Kiviniemi M; Suvisaari J; Koivumaa-Honkanen H; Häkkinen U; Isohanni M; Hakko H
Schizophr Res; 2013 Oct; 150(1):274-80. PubMed ID: 23953217
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
[TBL] [Abstract][Full Text] [Related]
17. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
18. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic study of aripiprazole use and the incidence of suicide events.
Ulcickas Yood M; Delorenze G; Quesenberry CP; Tsai AL; Phillips S; Willey VJ; Niemcryk SJ; Wells K; Skovron ML; Cziraky MJ; Carson W; Oliveria SA
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1124-30. PubMed ID: 20925132
[TBL] [Abstract][Full Text] [Related]
20. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
